Matches in SemOpenAlex for { <https://semopenalex.org/work/W4366990971> ?p ?o ?g. }
- W4366990971 endingPage "15" @default.
- W4366990971 startingPage "1" @default.
- W4366990971 abstract "Schizophrenia is a mental illness that can disrupt emotions, perceptions, and cognition and reduce quality of life. The classical approach to treat schizophrenia is to use typical and atypical antipsychotics; however, limitations include low efficacy in mitigating negative symptoms and cognitive dysfunctions and a range of adverse effects. Evidence has accumulated on trace amine-associated receptor 1 (TAAR1) as a novel therapeutic target for treating schizophrenia. This systematic review investigates the available evidence on a TAAR1 agonist, ulotaront, as a treatment for schizophrenia.A systematic search was conducted on PubMed/MEDLINE and Ovid databases for English-published articles from inception to 18 December 2022. The literature focusing on the association between ulotaront and schizophrenia was evaluated based on an inclusion/exclusion criterion. Selected studies were assessed for the risk of bias, using the Cochrane Collaboration tool, and summarized in a table to generate discussion topics.Three clinical, two comparative, and five preclinical studies examining ulotaront's pharmacology, tolerability and safety, and/or efficacy were identified. Results indicate that ulotaront has a differing adverse effect profile from other antipsychotics, may mitigate metabolic-related adverse effects commonly associated with antipsychotics, and may be effective for treating positive and negative symptoms.Findings from the available literature present ulotaront as a potential and promising alternative treatment method for schizophrenia. Despite this, our results were limited due to the lack of clinical trials on ulotaront's long-term efficacy and mechanisms of action. Future research should focus on these limitations to elucidate ulotaront's efficacy and safety for the treatment of schizophrenia and other mental disorders with similar pathophysiology." @default.
- W4366990971 created "2023-04-27" @default.
- W4366990971 creator A5007416915 @default.
- W4366990971 creator A5019103369 @default.
- W4366990971 creator A5021387325 @default.
- W4366990971 creator A5032486123 @default.
- W4366990971 creator A5034847365 @default.
- W4366990971 creator A5045499717 @default.
- W4366990971 creator A5068850044 @default.
- W4366990971 creator A5072363222 @default.
- W4366990971 creator A5076186053 @default.
- W4366990971 creator A5080826593 @default.
- W4366990971 creator A5086578802 @default.
- W4366990971 creator A5087184510 @default.
- W4366990971 date "2023-05-01" @default.
- W4366990971 modified "2023-10-01" @default.
- W4366990971 title "Efficacy, safety, and tolerability of ulotaront (SEP-363856, a trace amine-associated receptor 1 agonist) for the treatment of schizophrenia and other mental disorders: a systematic review of preclinical and clinical trials" @default.
- W4366990971 cites W1195814905 @default.
- W4366990971 cites W1524835549 @default.
- W4366990971 cites W1554040650 @default.
- W4366990971 cites W1785627328 @default.
- W4366990971 cites W1939484047 @default.
- W4366990971 cites W2000326325 @default.
- W4366990971 cites W2011355421 @default.
- W4366990971 cites W2011889986 @default.
- W4366990971 cites W2014026290 @default.
- W4366990971 cites W2024392942 @default.
- W4366990971 cites W2071537273 @default.
- W4366990971 cites W2073235937 @default.
- W4366990971 cites W2077622066 @default.
- W4366990971 cites W2085360366 @default.
- W4366990971 cites W2085926691 @default.
- W4366990971 cites W2087404956 @default.
- W4366990971 cites W2094969580 @default.
- W4366990971 cites W2097983973 @default.
- W4366990971 cites W2098923148 @default.
- W4366990971 cites W2100404514 @default.
- W4366990971 cites W2102457323 @default.
- W4366990971 cites W2120299904 @default.
- W4366990971 cites W2130322124 @default.
- W4366990971 cites W2138218422 @default.
- W4366990971 cites W2141403390 @default.
- W4366990971 cites W2142137999 @default.
- W4366990971 cites W2152770536 @default.
- W4366990971 cites W2153216347 @default.
- W4366990971 cites W2157457391 @default.
- W4366990971 cites W2158321076 @default.
- W4366990971 cites W2411013142 @default.
- W4366990971 cites W2415833410 @default.
- W4366990971 cites W2486451269 @default.
- W4366990971 cites W2585683277 @default.
- W4366990971 cites W2590283400 @default.
- W4366990971 cites W2746379998 @default.
- W4366990971 cites W2783313812 @default.
- W4366990971 cites W2784103524 @default.
- W4366990971 cites W2802172273 @default.
- W4366990971 cites W2804264444 @default.
- W4366990971 cites W2884510193 @default.
- W4366990971 cites W2888342366 @default.
- W4366990971 cites W2902279682 @default.
- W4366990971 cites W2913588197 @default.
- W4366990971 cites W2921430766 @default.
- W4366990971 cites W2947991910 @default.
- W4366990971 cites W2964999518 @default.
- W4366990971 cites W3015204490 @default.
- W4366990971 cites W3022484871 @default.
- W4366990971 cites W3123893780 @default.
- W4366990971 cites W3131715422 @default.
- W4366990971 cites W3152702086 @default.
- W4366990971 cites W3155391591 @default.
- W4366990971 cites W3176003006 @default.
- W4366990971 cites W3186490203 @default.
- W4366990971 cites W3200296049 @default.
- W4366990971 cites W3213184078 @default.
- W4366990971 cites W4200032489 @default.
- W4366990971 cites W4200212552 @default.
- W4366990971 cites W4200449691 @default.
- W4366990971 cites W4220959955 @default.
- W4366990971 cites W4224254536 @default.
- W4366990971 cites W4224313524 @default.
- W4366990971 cites W4225131709 @default.
- W4366990971 cites W4281769843 @default.
- W4366990971 cites W4289745759 @default.
- W4366990971 cites W4303614233 @default.
- W4366990971 doi "https://doi.org/10.1080/13543784.2023.2206559" @default.
- W4366990971 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37096491" @default.
- W4366990971 hasPublicationYear "2023" @default.
- W4366990971 type Work @default.
- W4366990971 citedByCount "4" @default.
- W4366990971 countsByYear W43669909712023 @default.
- W4366990971 crossrefType "journal-article" @default.
- W4366990971 hasAuthorship W4366990971A5007416915 @default.
- W4366990971 hasAuthorship W4366990971A5019103369 @default.
- W4366990971 hasAuthorship W4366990971A5021387325 @default.
- W4366990971 hasAuthorship W4366990971A5032486123 @default.
- W4366990971 hasAuthorship W4366990971A5034847365 @default.
- W4366990971 hasAuthorship W4366990971A5045499717 @default.
- W4366990971 hasAuthorship W4366990971A5068850044 @default.